Literature DB >> 17620837

Development of a new generation of propofol.

Haibo Wang1, Randall Cork, Ashock Rao.   

Abstract

PURPOSE OF REVIEW: The current advance in development of a new generation of propofol and its clinical implications are reviewed. RECENT
FINDINGS: All currently available formulations of propofol have side effects related to propofol itself, as well as to the emulsion delivery systems. A search for better and safer propofol continues. Improvement of the emulsion delivery systems is one of approaches, which can be achieved by identifying better inactive components, enhancing stability, and applying new technologies such as nanotechnology. Modification of chemical structure is another approach, particularly with the development of propofol prodrugs.
SUMMARY: There is a continuous need to develop a better and safer propofol. The development of a new propofol should be focused on minimizing the unwanted side effects, while preserving the beneficial profiles. Hopefully, just such a new propofol will be available in the near future for clinical use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620837     DOI: 10.1097/ACO.0b013e3281667777

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  4 in total

1.  Pain on injection with microemulsion propofol.

Authors:  Ji-Yeon Sim; Soo-Han Lee; Do-Yang Park; Jin-Ah Jung; Kyoung-Ho Ki; Dong-Ho Lee; Gyu-Jeong Noh
Journal:  Br J Clin Pharmacol       Date:  2008-12-10       Impact factor: 4.335

2.  Perspectives on the role of fospropofol in the monitored anesthesia care setting.

Authors:  Joseph V Pergolizzi; Tong J Gan; Stanford Plavin; Sumedha Labhsetwar; Robert Taylor
Journal:  Anesthesiol Res Pract       Date:  2011-04-14

3.  Halothane: Is there still any place for using the gas as an anesthetic?

Authors:  Ali Dabbagh; Samira Rajaei
Journal:  Hepat Mon       Date:  2011-07       Impact factor: 0.660

4.  The future of anaesthesiology.

Authors:  Ankit Agarwal
Journal:  Indian J Anaesth       Date:  2012-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.